The global Human Chorionic Gonadotropin (HCG) market is estimated to be valued at US$ 710.88 million in 2022 and is expected to exhibit a CAGR of 6.5% over the forecast period of 2022-2030. HCG is a hormone produced during pregnancy and is widely used in fertility treatments and weight loss therapies. The market is driven by the increasing prevalence of infertility, growing awareness about HCG therapies, and advancements in medical technology and drug ... Read more
Human chorionic gonadotropin or HCG is a hormone produced during pregnancy. With the rise of fertility issues and weight loss trends, this natural hormone has gained popularity and created new business opportunities. Let's take a deeper look at HCG's functions, medical uses, and emerging applications.
